Primaquine: Difference between revisions

Revision as of 01:53, 20 March 2026

Disease	Dose	Context
Pneumocystis jirovecii pneumonia	30mg PO q24hrs	Mild disease with Clindamycin
Pneumocystis jirovecii pneumonia	30mg PO once daily	Severe disease with Clindamycin

Allergy to class/drug
Concomitant use with other potentially hemolytic or myeloid suppressing drugs
Acutely ill patients with diseases prone to granulocytopenia (e.g. SLE or rheumatoid arthritis)

Authors:

@@ Line 6: / Line 6: @@
 ==Adult Dosing==
-*[[PCP pneumonia]], HIV+ : 15-30mg PO daily with clindamycin
+===Indications by Disease===
-*[[Malaria]] treatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent
+{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Adult]]
-*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure
+|?Treats disease=Disease
+|?Has Dose=Dose
+|?Has Context=Context
+|format=table
+|limit=50
+|mainlabel=-
+|headers=show
+|sort=Treats disease
+}}
 ==Pediatric Dosing==
-*[[Malaria]] treatment: 0.8 mg/kg PO daily (max 52.6mg daily) in combination with an additional anti-malarial agent
+===Indications by Disease===
-*[[Malaria]] prophylaxis: 0.8 mg/kg PO daily (max 52.6mg daily) starting 1-2 days prior to arrival in endemic area until 7-14 days after departure
+{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Pediatric]]
+|?Treats disease=Disease
+|?Has Dose=Dose
+|?Has Context=Context
+|format=table
+|limit=50
+|mainlabel=-
+|headers=show
+|sort=Treats disease
+}}
 ==Special Populations==